CollPlant Ltd (CLGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CollPlant Ltd (CLGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12104
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant’s wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant provides tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company also provides surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Ness Ziona, Israel.

CollPlant Ltd (CLGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
CollPlant Ltd, Medical Equipment, Deal Details 11
Partnerships 11
Lung Biotechnology Enters into Licensing Agreement with CollPlant 11
CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 12
CollPlant Enters into Distribution Agreement with Arthrex 13
CollPlant to Enter into Agreement with US based company 14
Equity Offering 15
CollPlant Raises USD2 Million in First Tranche of Private Placement 15
CollPlant to Raise Funds through Private Placement Shares and Warrants 16
CollPlant Raises USD1.9 Million in Equity Offering 17
CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 18
CollPlant Raises USD3 Million in Equity Offering 19
CollPlant Raises USD2 Million in Private Placement of Shares 20
CollPlant Raises USD2.3 Million in Private Placement of Shares 21
CollPlant Ltd – Key Competitors 22
CollPlant Ltd – Key Employees 23
CollPlant Ltd – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Strategy And Business Planning 25
Oct 23, 2018: CollPlant licences 3D bioprinting technology to United Therapeutics 25
Apr 23, 2018: CollPlant Opens New rhCollagen Production Facility In Israel 26
May 11, 2017: CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues 27
Financial Announcements 28
Sep 29, 2018: Collplant reports third quarter 2018 financial results and provides business update 28
Sep 21, 2018: CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update 30
May 24, 2018: CollPlant Announces First Quarter 2018 Financial Results 31
Mar 21, 2018: CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update 33
Corporate Communications 35
Jul 05, 2018: CollPlant Names Dr. Wolfgang Ruttenstorfer As Board Director 35
Jun 19, 2018: CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board 36
Apr 12, 2018: CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer 37
Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 38
Legal and Regulatory 39
Jun 26, 2018: CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs 39
Product News 40
May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler 40
Oct 30, 2017: Innovation Authority Gives Vote of Confidence: CollPlant Receives Innovation Authority Approval for USD One Million R&D Program with 40% Funding 41
Other Significant Developments 42
Feb 21, 2018: CollPlant Joins ReMDO’s Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs 42
Nov 28, 2017: CollPlant Receives Substantial, Repeat Order for Its Biological Ink 43
May 31, 2017: CollPlant Provides Operational Update for Q1 2017 44
Mar 30, 2017: CollPlant Provides Commercial and Operational Update 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
CollPlant Ltd, Medical Equipment, Key Facts, 2017 2
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Deals By Market, 2012 to YTD 2018 9
CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Lung Biotechnology Enters into Licensing Agreement with CollPlant 11
CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 12
CollPlant Enters into Distribution Agreement with Arthrex 13
CollPlant to Enter into Agreement with US based company 14
CollPlant Raises USD2 Million in First Tranche of Private Placement 15
CollPlant to Raise Funds through Private Placement Shares and Warrants 16
CollPlant Raises USD1.9 Million in Equity Offering 17
CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 18
CollPlant Raises USD3 Million in Equity Offering 19
CollPlant Raises USD2 Million in Private Placement of Shares 20
CollPlant Raises USD2.3 Million in Private Placement of Shares 21
CollPlant Ltd, Key Competitors 22
CollPlant Ltd, Key Employees 23

List of Figures
CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CollPlant Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[CollPlant Ltd (CLGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zeria Pharmaceutical Co Ltd (4559):企業の財務・戦略的SWOT分析
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Wipro Ltd:企業のM&A・事業提携・投資動向
    Wipro Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wipro Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Pioneer Natural Resources Co (PXD)-石油・ガス分野:企業M&A・提携分析
    Summary Pioneer Natural Resources Company (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activit …
  • Sunflower Electric Power Corp:企業の戦略的SWOT分析
    Sunflower Electric Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that offers healthcare research services. The institute offers research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offe …
  • Bailian Group Co., Ltd.:企業の戦略的SWOT分析
    Bailian Group Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Glavbolgarstroy Holdings AD:企業の戦略・SWOT・財務情報
    Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report Summary Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communit …
  • Sempra Energy (SRE):石油・ガス:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Black Hills Corporation (BKH)-エネルギー分野:企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Morinaga & Co., Ltd. (2201):企業の財務・戦略的SWOT分析
    Morinaga & Co., Ltd. (2201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Velatia SL:企業の戦略的SWOT分析
    Velatia SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • UniQuest Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Swarovski AG:企業の戦略・SWOT・財務情報
    Swarovski AG - Strategy, SWOT and Corporate Finance Report Summary Swarovski AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆